Showing results (2071-2080 of 2,162) with videos related to

Sort By:
Pageof 217
NPJ Breast Cancer|June 19, 2020
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemicMitch Dowsett, Matthew J Ellis, J Michael Dixon, et al.
Physical Review Letters|February 12, 2021
Precision Mass Measurements of Neutron-Rich Scandium Isotopes Refine the Evolution of N=32 and N=34 Shell ClosuresE Leistenschneider, E Dunling, G Bollen, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2018
Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and RadiomicsLuke Peng, Vishwa Parekh, Peng Huang, et al.
NPJ Breast Cancer|July 1, 2024
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studiesMaggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston, et al.
Mbio|March 10, 2016
Genomic Analysis of Salmonella enterica Serovar Typhimurium Characterizes Strain Diversity for Recent U.S. Salmonellosis Cases and Identifies Mutations Linked to Loss of Fitness under Nitrosative and Oxidative StressHillary S Hayden, Susana Matamouros, Kyle R Hager, et al.
Breast Cancer Research and Treatment|December 28, 2014
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II studyA R Tan, H Johannes, P Rastogi, et al.
Pediatric Blood & Cancer|January 8, 2021
Acceptability and feasibility of survivorship care plans and an accompanying mobile health intervention for adolescent and young adult survivors of childhood cancerSara King-Dowling, Alexandra M Psihogios, Christine Hill-Kayser, et al.
BMJ Open|May 30, 2025
Investigating mood and cognition in people with multiple sclerosis: a prospective cross-sectional study protocolElena C Cooper, Matthew K Schindler, Amit Bar-Or, et al.
Journal of Medical Genetics|January 7, 2005
The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypesS M Gribble, E Prigmore, D C Burford, et al.
Breast Cancer Research and Treatment|March 1, 2022
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)Charles E Geyer, Hanna Bandos, Priya Rastogi, et al.
Pageof 217